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Cell Surface-binding Sites for Progesterone Mediate  Calcium  Uptake 
in Human Sperm* 
(Received for publication, November 19,1990) 
Peter F. Blackmore$$, Joseph Neulenn 11, Frank LattanzioS,  and  Stephen J. Beebeq 
From  the  $Department of Pharmacology,  the  Department of Obstetrics  and Gynecology, and  the IIJones Institute for 
Reproductive  Medicine,  Eastern  Virginia  Medical School, Norfolk, Virginia 23501 
Recent studies (e.g. Blackmore, P. F., Beebe, S. J., 
Danforth, D. R., and Alexander, N.) (1990) J. Biol. 
Chem. 265, 1376-1380) have shown that in human 
sperm,  progesterone  produces a rapid  increase  in  in- 
tracellular  free calcium ([Ca”+li) and  an induction of 
the acrosome reaction (e.g. Osman, R. A., Andria, M. 
L., Jones, A. D., and Meizel, S.  (1989) Biochem.  Bio- 
phys.  Res. Commun. 160,828-833). 
In  this  study,  the location of progesterone  receptors 
on  the cell surface of human  sperm  was  identified  using 
progesterone immobilized on bovine serum albumin 
(BSA) (progesterone 3-(O-carboxymethyl)oxime:BSA) 
as well as progesterone and its 3-0-carboxymethylox- 
ime  derivative.  Using  fluorescence microscopy, BSA- 
fluorescein  isothiocyanate  was  shown  to  be  excluded 
from  intact  sperm,  thus  validating  the  use of proges- 
terone 3-(O-carboxymethyl)oxime:BSA to  identify cell 
surface-binding sites for progesterone. The immobi- 
lized progesterone and the 3-0-carboxymethyloxime 
derivative  rapidly  increased [Ca2+Ii and  were full  ag- 
onists,  although  they  were  approximately 1.5 orders 
of magnitude less potent than progesterone.  They  also 
displayed an identical  time  course  to  increase  [Ca2+Ii 
as free  progesterone,  and  the  entire  increase  in [Ca2+Ii 
was  due  to  the  influx of Ca2+. This  progesterone-me- 
diated response displayed different steroid receptor 
characteristics since the very potent inhibitors of 
genomic  progesterone  responses,  RU38486  and 
ZK98.299, were  very  ineffective at  inhibiting  the  pro- 
gesterone-mediated  increase  in [Ca2+Ii. Also the  syn- 
thetic  progestins  megestrol,  medroxyprogesterone  ace- 
tate,  norgestrel,  norethynodrel,  norethindrone, 
R5020, and cyproterone acetate did not mimic the 
effects of progesterone to increase [Ca2+Ii. It is pro- 
posed that a distinct nongenomic  cell surface  receptor 
for progesterone  exists in human  sperm. 
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Studies have shown that progesterone can induce the  ac- 
rosome reaction  in  capacitated  human  sperm  (Osman et al., 
1989). It  has also been  demonstrated  that progesterone and 
1701-hydroxyprogesterone can induce a rapid influx of Ca2+ 
into  either  capacitated or noncapacitated  human  sperm 
(Blackmore et al., 1990; Thomas and Meizel, 1989). The 
induction of the acrosome reaction is believed to follow this 
influx of Ca2+ (e.g. Yanagimachi, 1988; Sidhu and Guraya, 
1990). This rapid effect of progesterone to stimulate Ca2+ 
influx  indicates a nongenomic response  and suggests that a 
cell surface  receptor exists for progesterone  (Blackmore et al., 
1990). Since progesterone can penetrate the plasma mem- 
brane,  due  to  its hydrophobicity, one could  invisage that  the 
binding site for progesterone could conceivably be located 
intracellularly. 
The best  characterized cell surface  progesterone  receptor is 
from the Xenopus oocyte (Sadler and Maller, 1985), where 
progesterone reduces  endogenous CAMP levels by inhibiting 
adenylylcyclase. There  are  other more recent  reports of non- 
genomic  effects of steroids. For example, progesterone  causes 
the release of gonadotropin-releasing  hormone from rat hy- 
pothalami via  a plasma  membrane receptor (Ke  and Ramirez, 
1987, 1990). Progesterone was also  shown to  enhance T -  
aminobutyric acid  effects on  neuronal C1- ion  channels  (Wu 
et al., 1990).  The  present evidence  shows that progesterone as 
well as other steroids bind to a “distinct membrane-bound 
steroid site” (Gee et al., 1987; Lan et al., 1990). The rapid 
membrane effects of steroid  hormones were recently reviewed 
by Schumacher  (1990),  Touchette  (1990),  and McEwen 
(1991). 
To investigate  the  mechanism by which the progesterone 
receptor  can regulate the  uptake of  Ca’+ by sperm  and increase 
[Ca”],  it  is  imperative  that  the subcellular location of the 
progesterone  receptor be identified. If it is suspected  that  the 
receptor is in  the  plasma  membrane  and  the  binding  site for 
progesterone  is  on  the  extracellular  surface,  then use can be 
made of immobilized progesterone. Immobilized ligands, if 
coupled to large  molecular  weight molecules that  cannot  pen- 
etrate  the  plasma  membrane  and if the  essential  determinants 
for the ligands  specificity and  activity  are  still exposed, can 
stimulate cell surface  receptors (e.g. Dehaye et al., 1980). In 
the  present  study, we utilized progesterone  (prog)’ covalently 
linked at  position 3 on  the  steroid nucleus  via an O-carboxy- 
methyloxime (CMO) to bovine serum albumin (BSA) (prog 
CMO BSA). I t  was found  that prog CMO BSA was able to 
stimulate a rapid  increase  in [Ca”],. 
’ The abbreviations used are: prog,  progesterone;  CMO,  O-carbox- 
ymethyloxime;  BSA,  bovine serum  albumin;  FITC-BSA, bovine 
serum  albumin-fluorescein  isothiocyanate;  EGTA,  [ethylenebis(oxy- 
ethylenenitrilo)]tetraacetic acid. 
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MATERIALS AND METHODS 
Human  sperm,  either  capacitated or noncapacitated, were  isolated 
as previously described (Blackmore et al., 1990). The same results 
were obtained with either  sperm  preparation  (data  not  shown).  Sperm 
were loaded with fura-2 and fluorescence measurements made as 
detailed before (Blackmore et al., 1990). Prog CMO BSA, BSA- 
fluorescein isothiocyanate (FITC-BSA), and Prog CMO were from 
Sigma.  The  particular  preparation of prog CMO BSA had 31 mol of 
progesterone/mol of BSA. RU38486 was  from  Roussel-Uclaf, France, 
and ZK98.299 was from Schering Ag (F.R.G.). Other steroids were 
lrom  Sigma. 
Free  progesterone  was removed from various  solutions  as follows. 
A solution (100 pl) of prog CMO BSA (100 p ~ )  was incubated a t  
room temperature with  a slurry (20 pl) of activated  charcoal (charcoal 
0.5 g/ml, BSA 4 mg/ml).  After  removal of the  charcoal by centrifu- 
gation (2000 X g for 5 min), the supernatant solution should only 
contain progesterone  covalently  bound to BSA (see Fig. 6 for results). 
T o  confirm that charcoal did remove free progesterone and CMO 
progesterone from aqueous solution,  charcoal was added, as above, to 
a solution of free  progesterone  (100 p ~ )  or CMO  progesterone  con- 
taining 100 pM BSA (see Fig. 6  for results). 
Fluorescence and light microscopy were performed  using  a Nikon 
microphot-FX.  Suspensions of sperm were mixed with 10 pM FITC- 
HSA for 1 h in the presence (0.05% w/v) of digitonin or in  its absence. 
Images were recorded on  VHS videotape  using  a MTI CCD72 camera 
and a videoscope image intensifier. Images  were printed  on a Sony 
video printer UP-5OOOW. 
RESULTS 
Fig. 1 shows the temporal effects of progesterone, prog 
CMO, and prog CMO BSA (10 p~ progesterone covalently 
bound)  to increase [Ca’Ii. This  concentration of prog CMO 
BSA was equivalent to  the effect  observed with 10 p~ proges- 
terone and was the maximum effect seen with prog CMO 
BSA. Thus, prog  CMO BSA acted  as a  full  agonist. The  time 
course of prog CMO BSA to elevate [Ca2+Ii was very similar 
to that seen with progesterone; all agents elevated [Ca2++Ii 
without apparent delay. The BSA control did not elevate 
[Ca’+], which is not  surprising  since  the media  already  con- 
tained 3.0 mg/ml BSA (data not shown). Fig. 2 shows the 
concentration response  curve  for prog CMO BSA to elevate 
[Ca’+Ii compared with the effect of progesterone and prog 
CMO. Progesterone was more potent  than  either prog  CMO 
or prog  CMO BSA. The ECso for  progesterone was approxi- 
mately 50 nM, whereas the ECso for prog CMO BSA was 
approximately 1 p ~ .  However, prog CMO and prog CMO 
BSA were essentially equipotent, indicating that the BSA 
s 0- 
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FIG. 1. Time  course  of  progesterone, prog CMO  BSA,  and 
prog CMO to increase [Ca”Ii in   sperm.   To fura-2-loaded sperm, 
10 p~ progesterone, 10 p~ prog CMO BSA, or 10 p~ prog  CMO were 
added a t  15 s (arrow). The  sperm were loaded  with  fura-2 as described 
under  “Materials  and Methods.” The prog CMO BSA was dissolved 
in 0.1% BSA, 1.50 mM NaC1, while the progesterone and  prog CMO 
were dissolved in dimethyl sulfoxide. Each  agonist produced an im- 
mediate increase in [Ca”],, which reached a maximum value after 
approximately 30 s. A representative  experiment is shown. 
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FIG. 2. Concentration  response  curves  of progesterone, 
prog  CMO,  and prog CMO  BSA to increase [Ca’+Ii in   sperm.  
The various agents were added a t  the indicated concentrations  and 
the peak [Ca‘+]i measured  usually 30 s after  the  addition of the agent. 
See Fig. 1 legend for other details. Data  are  means f S.E. from three 
separate  experiments. 
FIG. 3. Light  and  fluorescence  microscopy  of  sperm  in the 
presence  of  FITC-BSA (10 p ~ )  and the  effect   of  digitonin on 
the  fluorescence.  Sperm were mixed with 10 p~ FITC-BSA  then 
placed on a microscope slide coverslip. Cells were observed using a 
Fluor 1 0 0 ~  objective. Images of sperm were recorded on videotape. 
see “Materials  and Methods.” 
Representative  sperm  are shown for each  condition. For  other details, 
added was not  in itself  responsible  for the reduced potency, 
even though prog  CMO BSA cannot cross the plasma mem- 
brane. Consequently, the  actions of prog  CMO and prog  CMO 
BSA can be accounted  for by their extracellular  actions. 
To  confirm that BSA was confined to the extracellular 
space, FITC-BSA was added to sperm suspensions in the 
presence (Fig. 3, panels C and D )  and absence (panels A and 
B )  of digitonin (0.05% w/v). The data in Fig. 3 show a 
representative  experiment  in which sperm  in  the presence of 
FITC-BSA were examined  under  light microscopy (panels A 
and C) and fluorescence microscopy (panels B and D) .  Panel 
A shows an intact sperm under light microscopy; however, 
the same sperm under fluorescence microscopy (panel B )  
demonstrate  that  FITC-BSA  is excluded. Conversely, when 
sperm were treated  with digitonin to  render  them permeable, 
FITC-BSA was localized intracellularly (panel D ) .  This result 
confirms  the  rationale for using  the progesterone BSA con- 
jugate  to localize cell surface  progesterone  receptors. 
It was previously shown that progesterone was able to 
promote an increase in [Ca2+Ii by stimulating Ca2+ influx 
rather  than a  release of intracellular Ca2+  (Blackmore et al., 
1990). The prog CMO  BSA-stimulated increase  in [Ca’+Ii was 
also due to  an influx of extracellular Ca’+, since the response 
was completely inhibited when extracellular Ca2+ was re- 
moved by chelation with the Ca2+ chelator EGTA (Fig. 4). 
The readdition of Ca’+ to  the  EGTA-treated cells that were 
previously exposed to prog  CMO BSA resulted  in an imme- 
diate increase  in [Ca”]i similar  to  that observed when Ca2+ 
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FIG. 4. Effect of EGTA and La3+ on prog CMO BSA (1 p ~ )  
induced increase in [Ca*+];. Fura-2-loaded sperm were treated  with 
prog CMO BSA at  15 s (arrow) in the presence of  Ca2' (2.5 mM), in 
the presence of 3.0 mM EGTA (added at zero time), or 200 FM La3+ 
(added  at zero time). To  the  EGA-treated cells a t  50 s, 3.0 mM Ca" 
was added  back. A representative  experiment of three is shown. 
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FIG. 5. Effect of prog CMO BSA (10 pM) and prog (10 pM) 
to induce Ca*+ influx  measured by observing  the ability of 
Mn*+ added extracellularly to quench  fura-2. To  sperm loaded 
with fura-2, 1 mM Mn2+ was added  together  with  the various agents 
a t  15 s (arrow). The excitation fluorescence used was 360 nm, the 
isosbestic point of fura-2. The specificity of the Mn" for the Ca" 
channel was verified by observing that  the Ca" channel  antagonist 
La:" (200 IM) effectively blocked the Mn2+-induced quenching of 
fura-2. 
was initially present. Also shown  in Fig. 4 is  the effect of the 
nonselective Ca2+  channel blocker, La3+, which also  inhibited 
the prog  CMO  BSA-induced increase  in [Ca2+Ii. These  data 
show  that immobilized  prog CMO  BSA  promotes  an  increase 
in  [Ca2+], by stimulating  Ca2+ influx. 
Another  sensitive  measure of Ca2+  influx  is  to  determine 
the  rate of intracellular  fura-2  quenching by Mn2+  (Hallam 
and  Rink, 1985). The  divalent  cation  Mn2+  is  carried by Ca2+ 
channels, hence its  influx  into cells is a measure of Ca2+  influx 
activity  (Rink, 1990; Merritt et al., 1989). The  data  in Fig. 5 
show  that prog CMO BSA and  progesterone  cause  an  imme- 
diate decline in fura-2 fluorescence induced by Mn2+. Al- 
though  not shown, the dose response for the  Mn2+-induced 
quenching of fura-2 elicited by prog CMO BSA correlates 
very closely with the rise in  [Ca2+Ji  measured  with  fura-2 (Fig. 
2). 
To eliminate  the possibility that  there was no  free proges- 
terone or prog CMO in the  prog  CMO BSA preparation  that 
was eliciting the increase in [Ca2+Ji, the prog CMO BSA 
preparation was treated with charcoal to remove noncova- 
lently  bound progesterone or prog CMO. The  data  in Fig. 6 
show that  the  charcoal  treatment  had  no effect on  the  ability 
of 1 pM prog CMO BSA to increase [Ca2+Ji. Charcoal was, 
however,  capable of removing noncovalently  bound  progester- 
0 30 60 90 120 
TIME (SEC) 
FIG. 6. Effect of charcoal  treatment on the ability of prog 
CMO BSA and  progesterone to elevate [Ca2+]i. A  solution of 100 
@M prog CMO BSA was treated with charcoal to remove traces of 
free  progesterone. The prog  CMO BSA solution was diluted 100-fold 
into  the  sperm suspension to give a  final concentration of 1 FM. Also, 
a  solution of 100 PM free  progesterone  in the presence of 100 PM BSA 
was treated with charcoal. See "Materials and Methods" for other 
details.  A representative  experiment is shown. 
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FIG. 7. Concentration response curves for progesterone, 
norethindrone, R5020, and cyproterone  acetate to increase 
[Ca*+]i. See legend to Fig. 2 for details. 
one  from  albumin (Fig. 6)  and prog CMO  (data  not  shown). 
These  data show that  the prog CMO BSA did not contain 
any free progesterone or prog CMO. Thus,  the observed  effects 
of prog CMO BSA on  [Ca2+Ii were due  to covalently  bound 
progesterone  and  not free  progesterone or prog CMO  in  the 
prog  CMO BSA. 
The  data  presented above clearly show that  the progester- 
one receptor  responsible  for mediating  Ca2+ influx  resides on 
the  extracellular surface of the  sperm  and  not  on  the  intra- 
cellular  surface. I t  was of interest  to  compare  this cell surface 
receptor  with  the  intracellular genomic receptor  and  the Xen- 
opus oocyte surface  progesterone receptor  regarding pharma- 
cological characteristics. The synthetic progestin agonists 
R5020 and  norethindrone elicited  a small increase in  intra- 
cellular  free Ca2+  but only at high concentrations  and  to nly 
approximately  10% of the  maximum effect  elicited by proges- 
terone  and prog CMO BSA  (Fig. 7). The antiandrogen cypro- 
terone  acetate, which is  also a potent  progestin  (Neri,  1976), 
was also  without effect on  [Ca2+Ii (Fig.  7). In  addition  to  the 
data shown in Fig. 7, the  data  in  Table I show the effect of 
several  other  progestins  on [Ca2+Ii. It  can  be  seen  that only 
17a-hydroxyprogesterone and 11a-hydroxyprogesterone had 
effects on [Ca"+li similar  to  that observed  with  progesterone. 
On  the  other  hand,  the  potent  synthetic genomic progestins 
megestrol, medroxyprogesterone acetate, norgestrel, noreth- 
indrone, and norethynodrel (Gilman et al., 1990) were very 
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TABLE I
Effect  of various progestins  on [CU"]~ in  human  sperm 
The data shown are the means f S.E. from three separate experi- 
ments. Each steroid was dissolved in dimethyl sulfoxide and was 
added at a final concentration of 10 FM. The peak responses on 
[Ca"], were expressed as 7% of the maximum progesterone effect 
observed. 
Progestin Increase in [Ca"], expressed as  % of maximum progesterone  effect 
Progesterone 100 
17a-Hydroxyprogesterone 133 -C 10 
lla-Hydroxyprogesterone 102 k 7 
21-Hydroxyprogesterone or 32 k 6.9 
Megestrol 5 + 5  
Medroxyprogesterone acetate 14 k 3 
Norgestrel 
Norethindrone 
1 f 1.3 
Norethynodrel 
8 k 4  
12 f 2 
(11-deoxycorticosterone) 
LOG MOLAR PROGESTERONE 
FIG. 8. Concentration response curves of progesterone to 
increase [Caz+Ii in the presence and absence of 10 p~ 
ZK98.299 or 10 p~ RU38486. To fura-2-loaded sperm, 10 p M  
ZK98.299 or 10 PM RU38486 was added 15 s before the addition of 
progesterone. The peak responses were measured, which usually 
occurred 20-30 s after the progesterone additions.  The data shown 
are the mean from three separate experiments. 
weak agonists on the elevation of [Ca2+]; in sperm. The 
addition of a  hydroxyl  group on  the 21-position of progester- 
one (11-deoxycorticosterone or 21-hydroxyprogesterone) pro- 
foundly  reduced the  ability of the compound to elevate 
[Ca2+];. 
The effect of the two potent genomic antiprogestins 
ZK98.299 and RU38486 (Baulieu,  1989)  was also  examined  to 
see  whether  they would block progesterone-mediated  in- 
creases [Ca"];. The  data  in Fig. 8 show that  either  antagonists 
at 10 PM had small inhibitory effects over a wide range of 
progesterone  concentrations.  In  another  set of experiments, 
various  concentrations of both  antiprogestins RU38486 and 
ZK98.299 were examined  to see if they would inhibit a sub- 
maximal (-80%  of maximum)  concentration of progesterone 
(0.1 VM). The data in Fig. 9 show that equimolar doses of 
ZK98.299 and RU38486 (i.e. 0.1 FM) had a small  inhibitory 
effect. However, when  a  large  1000-fold  excess of each antag- 
onist was added, nearly complete inhibition was observed. 
This  is  in  contrast  to  the  antagonism of genomic progesterone 
actions  that requires a 10-fold lower concentration of 
RU38486 to completely block progesterone effects. RU38486 
and  many  synthetic  progestins have  a  higher affinity for the 
genomic  progesterone  receptor than  progesterone  with a Kd 
< 1 nM (Baulieu 1989). These data indicate that the cell 
surface progesterone  receptor  responsible  for  eliciting an  in- 
crease in [Ca'+], is distinct from the intracellular genomic 
120 
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FIG. 9. Concentration response curves of ZK98.299 or 
RU38486 to inhibit 0.1 p~ progesterone-mediated increases 
in [Ca2+Ii. See  legend to Fig. 8 for details.  The data shown are the 
mean from three separate experiments. 
progesterone receptor from the standpoint of agonist and 
antagonist specificity. 
DISCUSSION 
The  data  presented  in  this  study clearly  show that proges- 
terone immobilized by covalent linkage to BSA is capable of 
eliciting Ca2+  influx  in  human  sperm.  The  most likely conclu- 
sion  to be drawn  from  the  present  results  is  that  there  is a 
receptor that is present in the plasma membrane of the 
spermatozoa  and  that  the  progesterone-binding  site resides in 
that  portion of the  receptor  that is exposed to  the  extracellular 
space. 
The  presence of a  carboxymethyloxime  group on  carbon 3 
of progesterone reduced its  sensitivity for inducing  the  Ca2+ 
influx (Fig.  2).  However, this  is  not  surprising since  relatively 
small modifications of the progesterone molecule result  in a 
loss of potency for this response (Blackmore et al., 1990). 
Since prog CMO and prog CMO BSA were equipotent,  the 
presence of BSA esterified to  the carboxymethyloxime linker 
had no influence on the activity of prog CMO to elicit its 
effects at the progesterone-binding site. Furthermore, both 
prog CMO and prog CMO BSA  produced the  same  time  action 
(Fig. 1) and maximal responses (Fig. 2) as progesterone, 
suggesting that  it  was the  CMO derivative rather  than  the 
exclusion from  the  sperm  cytoplasm  that was responsible  for 
the reduced  potency. These  data also  show that  the increase 
in  [Ca2+Ii nduced  by  prog CMO BSA was not  due  to proges- 
terone or prog CMO being liberated  during  the  incubation, 
since prog CMO BSA, prog CMO, and progesterone had 
identical  time  courses to  elevate  [Ca2+Ii. One would expect  a 
slower time course or lag with the prog CMO BSA if the 
progesterone or  prog CMO had  to be liberated by hydrolysis 
first before it could stimulate  Ca2+ influx.  However, this was 
not observed. 
Evidence has been presented  to  support  the  notion  that cell
surface steroid receptors do exist in several other systems 
(e.g. Godeau et al., 1978; Ishikawa et al., 1977; Ke and  Ramirez, 
1990). Having identified that  the  progesterone-binding moiety 
is  present  in  the  plasma  membrane of the  sperm  and  that  it 
is  distinct  from  the cytosolic nuclear progesterone receptor, 
then  one  can  consider various  possibilities whereby this recep- 
tor  can couple to  the  mechanism  that is responsible for  the 
Ca2+  entry process. Some possibilities are  as follows. 1) The 
generation of an inositol  lipid breakdown  product may pro- 
mote Ca2+ influx. However, evidence suggests that inositol 
lipid breakdown occurs following an elevation in [Ca'+Ii 
(Blackmore et al., 1990; Roldan  and  Harrison, 1989; Thomas 
and Meizel,  1989).  2) The  progesterone  receptor  activates a  G 
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protein  (Birnbaumer et al., 1990) that  then  activates  the  Ca2+ 
channel.  The  latter possibility  does not  appear  to  be  operative 
since  the nonselective G protein activator AlF, (e.g. Black- 
more et al., 1985) failed to  promote  Ca2+  influx  (Blackmore et 
al., 1990). 3) The progesterone receptor may stimulate a 
protease  that  activates  the  Ca2+  influx process. In  support of 
this possibility is the observation that the human sperm 
acrosome reaction  is  inhibited by proteinase  inhibitors  (De- 
Jonge et al., 1989). 4) The progesterone receptor activates 
some  other second  messenger system,  such as phospholipase 
D, which if activated would elevate  phosphatidic acid levels 
(e.g.  Bocckino et al., 1987). This activity has been demon- 
strated  in sea urchin sperm (Domino et al., 1989). Perhaps 
phosphatidate  acts  as a second  messenger to  elevate [Ca2+Ir 
(see Bocckino et al. (1987) for  references). 5 )  The progesterone 
receptor is a Ca" channel or a binding  site  on a Ca2+  channel 
analogous  to  the  steroid-binding  site  on  the  neuronal C1- ion 
channel (Wu et al., 1990).  6)  The  progesterone  receptor cou- 
ples directly to a Ca2+  channel by some unknown  mechanism. 
Another  feature of the  data  presented  is  the lack of simi- 
larity of this receptor to  the genomic progesterone  receptor 
in regard to  steroid selectivity. The  synthetic genomic agonists 
R5020, norgestrel, norethynodrel, medroxyprogesterone ace- 
tate, megestral, and norethindrone were very weak partial 
agonists,  and  the  potent genomic antiprogestins RU38486 and 
ZK98.299 were very weak antagonists of the progesterone 
effects  in  sperm (Figs. 8 and  9)  compared  with  their  potency 
in  affecting  the genomic receptor. 
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Addendum-After the submission of this manuscript, another 
study was submitted showing that prog CMO BSA stimulated the 
sperm acrosome reaction (Meizel and  Turner, 1991). 
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